SAN DIEGO ? The glucagon-like peptide 1 receptor agonist exenatide decreases body mass index (BMI) and body weight and improves risk factors for diabetes in children and adolescents who are extremely obese, according to the results of a small study reported at the 71st Scientific Sessions of the American Diabetes Association (ADA). Aaron S?
Read the full article here!
Retrieved via medicalnewstoday.com.
Source: http://thehealthessentials.info/exenatide-may-produce-weight-loss-in-obese-youth/
ebert wonderwall hpv celexa weight loss tips musa james blake
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.